Founded in 2008, Adarza has developed a highly sensitive label-free diagnostic platform capable of measuring 100s more individual proteins than the best multiplex immunoassays available today. The Arrayed Imaging Reflectometry (AIR™) is a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid. Adarza delivers industry leading precision, accuracy, and robustness enabling highly multiplexed protein detection with high sensitivity and specificity. The company’s unique technology is flexible, data-rich, and easy to use, providing the only solution that spans the entire companion diagnostic life cycle from discovery to clinic, in both high-throughput core facilities as well as point of care (POC). Much like the first gene-chips enabled multiplexed genomics analysis, Adarza’s first-to-market high-multiplex and sensitivity antibody chips will fundamentally disrupt the field of proteomics research. Adarza is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at University of Rochester by Dr. Benjamin Miller, Adarza’s scientific founder.
Show more
West Henrietta, US
Size (employees)
29 (est)
Adarza BioSystems was founded in 2008 and is headquartered in West Henrietta, US
Report incorrect company information

Adarza BioSystems Office Locations

Adarza BioSystems has offices in West Henrietta and Saint Peters
West Henrietta, US (HQ)
150 Lucius Gordon Dr
Saint Peters, US
501 Pearl Dr
Show all (2)
Report incorrect company information

Adarza BioSystems Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$31.1 m

Latest funding size

$17 m

Time since last funding

a year ago


Adarza BioSystems's latest funding round in January 2017 was reported to be $17 m. In total, Adarza BioSystems has raised $31.1 m
Report incorrect company information